Current Neuro-Oncology

Volume 22 Number 21
15 November 2020

Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 21, 15 November

Dejaegher J, Solie L, Hunin Z, Sciot R, Capper D, Siewert C, Van Cauter S, Wilms G, van Loon J, Ectors N, Fieuws S, Pfister SM, Van Gool SW, De Vleeschouwer S.
DNA Methylation based glioblastoma subclassification is related to tumoral T cell infiltration and patient survival.
Neuro Oncol. 2020 Nov 1, 2021;23(2):240-250. doi: 10.1093/neuonc/noaa247. PMID: 33130898. Laboratory investigation. ˍ

Dono A, Takayasu T, Ballester LY, Esquenazi Y.
Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.
J Clin Neurosci. 2020 Nov 1, 2020 Dec 1;82(Pt A):1-8
. doi: 10.1016/j.jocn.2020.10.005. PMID: 33317715. Observational study. ˍ

Hallaert G, Pinson H, Vanhauwaert D, Van den Broecke C, Van Roost D, Boterberg T, Kalala JP.
Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.
Surg Oncol. 2020 Nov 1, 2020;35:515-519. doi: 10.1016/j.suronc.2020.10.016. PMID: 33152608. Observational study. ˍ

Jiang H, Deng G, Liu B, Cheng J, Li Y, Tan Y, Wang J, Chen Q.
Analysis of the short-term outcomes and risk factors of seizure relapse in patients with gliomas after antiepileptic drugs withdrawal.
J Clin Neurosci. 2020 Nov 1, 2020 Dec 1;82(Pt A):20-25
. doi: 10.1016/j.jocn.2020.09.051. PMID: 33317732. Observational study. ˍ

Klein M, Drijver AJ, van den Bent MJ, Bromberg JC, Hoang-Xuan K, Taphoorn MJB, Reijneveld JC, Ben Hassel M, Vauleon E, Eekers DBP, Tzuk-Shina T, Lucas A, Freixa SV, Golfinopoulos V, Gorlia T, Hottinger AF, Stupp R, Baumert BG.
Memory in low-grade glioma patients treated with radiotherapy or Temozolomide. A correlative analysis of EORTC study 22033-26033.
Neuro Oncol. 2020 Nov 1, 2021;23(5):803-811 10.1093/neuonc/noaa252. PMID: 33130890. Observational study. ˍ

Pierscianek D, Ahmadipour Y, Michel A, Rauschenbach L, Darkwah Oppong M, Deuschl C, Kebir S, Wrede KH, Glas M, Stuschke M, Sure U, Jabbarli R.
Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.
Clin Neurol Neurosurg. 2020 Nov 1, 2021;200:106348. doi: 10.1016/j.clineuro.2020.106348. PMID: 33158630. Observational study. ˍ

Alkanhal H, Das K, Rathi N, Syed K, Poptani H.
Differentiating non enhancing grade II gliomas from grade III gliomas using diffusion tensor imaging and dynamic susceptibility contrast MRI.
World Neurosurg. 2020 Nov 2, 2021;146:e555-e564. doi: 10.1016/j.wneu.2020.10.144. PMID: 33152494. Observational study. ˍ

Faulkner H, Arnaout O, Hoshide R, Young IM, Yeung JT, Sughrue ME, Teo C.
The Surgical Resection of Brainstem Glioma: Outcomes and Prognostic Factors.
World Neurosurg. 2020 Nov 2, 2021;146:e639-e650. doi: 10.1016/j.wneu.2020.10.147. PMID: 33152495. Observational study. ˍ

Ferrante P, Mora JA, Salazar L, Sáez EM, Auger C, Rovira À.
MR imaging findings in primary spinal cord glioblastoma.
Radiol Case Rep. 2020 Nov 2, 2021;16(1):72-77. doi: 10.1016/j.radcr.2020.10.043. PMID: 33193932. Case report. ˍ

Nakada M, Nakajima R, Okita H, Nakade Y, Yuno T, Tanaka S, Kinoshita M.
Awake surgery for right frontal lobe glioma can preserve visuospatial cognition and spatial working memory.
J Neurooncol. 2020 Nov 2, 2021;151(2):221-230. doi: 10.1007/s11060-020-03656-9. PMID: 33136234. Observational study. ˍ

Wright KD, Yao X, London WB, Kao PC, Gore L, Hunger S, Geyer R, Cohen KJ, Allen JC, Katzenstein HM, Smith A, Boklan J, Nazemi K, Trippett T, Karajannis M, Herzog C, Destefano J, Direnzo J, Pietrantonio J, Greenspan L, Cassidy D, Schissel D, Perentesis J, Basu M, Mizuno T, Vinks AA, Prabhu SP, Chi SN, Kieran MW.
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.
Pediatr Blood Cancer. 2020 Nov 2, 2021;68(2):e28787. doi: 10.1002/pbc.28787. PMID: 33140540. Interventional study. ˍ

Anghileri E, Di Ianni N, Paterra R, Langella T, Zhao J, Eoli M, Patanè¨ M, Pollo B, Cuccarini V, Iavarone A, Rabadan R, Finocchiaro G, Pellegatta S.
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.
Cancer Immunol Immunother. 2020 Nov 3, 2021;70(3):831-842. doi: 10.1007/s00262-020-02769-4. PMID: 33140187. Case report. ˍ

Jiang H, Yu K, Li M, Cui Y, Ren X, Yang C, Zhao X, Lin S.
Classification of Progression Patterns in Glioblastoma: Analysis of Predictive Factors and Clinical Implications.
Front Oncol. 2020 Nov 3, 2020;10:590648
. doi: 10.3389/fonc.2020.590648. PMID: 33251147. Observational study. ˍ

Rades D, Witteler J, Schild SE.
Radiotherapy of Grade III Gliomas: Identification of Clinical Prognostic Factors for Local Tumor Control and Survival.
In Vivo. 2020 Nov 3, 2020;34(6):3627-3630. doi: 10.21873/invivo.12208. PMID: 33144477. Observational study. ˍ

Tunthanathip T, Ratanalert S, Sae-Heng S, Oearsakul T, Sakarunchai I, Kaewborisutsakul A, Chotsampancharoen T, Intusoma U, Kitkhuandee A, Vaniyapong T.
Prognostic factors and clinical nomogram predicting survival in high-grade glioma.
J Cancer Res Ther. 2020 Nov 3, 2021;17(4):1052-1058
. doi: 10.4103/jcrt.JCRT_233_19. PMID: 34528563. Observational study. ˍ

Witteler J, Schild SE, Rades D.
Clinical Prognostic Factors for Local Control and Survival After Irradiation of Grade II Gliomas.
In Vivo. 2020 Nov 3, 2020;34(6):3719-3722. doi: 10.21873/invivo.12220. PMID: 33144489. Observational study. ˍ

Fontanilles M, Marguet F, Beaussire L, Magne N, Pépin LF, Alexandru C, Tennevet I, Hanzen C, Langlois O, Jardin F, Laquerrière A, Sarafan-Vasseur N, Di Fiore F, Clatot F.
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.
Acta Neuropathol Commun. 2020 Nov 4, 2020;8(1):179. doi: 10.1186/s40478-020-01057-7. PMID: 33148330. Observational study. ˍ

Booth TC, Luis A, Brazil L, Thompson G, Daniel RA, Shuaib H, Ashkan K, Pandey A.
Glioblastoma post-operative imaging in neuro-oncology: current UK practice (GIN CUP study).
Eur Radiol. 2020 Nov 5, 2021;31(5):2933-2943. doi: 10.1007/s00330-020-07387-3. PMID: 33151394. Observational study. ˍ

Chen K, Huang B, Yan S, Xu S, Li K, Zhang K, Wang Q, Zhuang Z, Wei L, Zhang Y, Liu M, Lian H, Zhong C.
Two machine learning methods identify a metastasis-related prognostic model that predicts overall survival in medulloblastoma patients.
Aging (Albany NY). 2020 Nov 5, 2020;12(21):21481-21503. doi: 10.18632/aging.103923. PMID: 33159021. Observational study. ˍ

Zador Z, Landry AP, Saha A, Cusimano MD.
Gene Expression Signatures Identify Biologically Homogenous Subgroups of Grade 2 Meningiomas.
Front Oncol. 2020 Nov 5, 2020;10:541928. doi: 10.3389/fonc.2020.541928. PMID: 33224871. Laboratory investigation. ˍ

Ceccon G, Lohmann P, Werner JM, Tscherpel C, Dunkl V, Stoffels G, Rosen J, Rapp M, Sabel M, Herrlinger U, Schaefer N, Shah NJ, Fink GR, Langen KJ, Galldiks N.
Early treatment response assessment using 18F-FET PET compared to contrast-enhanced MRI in glioma patients following adjuvant temozolomide chemotherapy.
J Nucl Med. 2020 Nov 6, 2021;62(7):918-925. doi: 10.2967/jnumed.120.254243. PMID: 33158907. Observational study. ˍ

Kuroiwa M, Murata T, Hirayama S, Hokama M, Miyashita T.
Very small vestibular schwannoma as the source of fatal subarachnoid hemorrhage: a case report.
Br J Neurosurg. 2020 Nov 6:1-4. doi: 10.1080/02688697.2020.1844147. PMID: 33155858. Case report. ˍ

Li J, Huang W, Piao M, Liu Z, Ji S, Xue J, Zhu X.
Efficacy of bevacizumab combined with temozolomide dose-dense regimen on recurrent glioma.
J BUON. 2020 Nov 6, 2021;26(1):145-151
. PMID: 33721445. Observational study. ˍ

Yu L, Zhang G, Qi S.
Aggressive Treatment in Glioblastoma: What Determines the Survival of Patients?
J Neurol Surg A Cent Eur Neurosurg. 2020 Nov 6, 2021 Mar;82(2):112-117
. doi: 10.1055/s-0040-1713172. PMID: 33157564. Observational study. ˍ

Zhang M, Li R, Pollom EL, Amini A, Dandapani S, Li G.
Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.
J Clin Neurosci. 2020 Nov 6, 2020 Dec 1;82(Pt A):122-127
. doi: 10.1016/j.jocn.2020.10.049. PMID: 33317719. Observational study. ˍ

Chandra A, Lopez-Rivera V, Dono A, Brandel MG, Lewis C, O'Connor KP, Sheth SA, Ballester LY, Aghi MK, Esquenazi Y.
Comparative Analysis of Survival Outcomes and Prognostic Factors of Supratentorial versus Cerebellar Glioblastoma in the Elderly: Does Location Really Matter?
World Neurosurg. 2020 Nov 7, 2021;146:e755-e767. doi: 10.1016/j.wneu.2020.11.003. PMID: 33171326. Observational study. ˍ

Maas SLN, van Solinge TS, Schnoor R, Yekula A, Senders JT, de Vrij J, Robe P, Carter BS, Balaj L, Arkesteijn GJA, Nolte-'t Hoen ENM, Broekman MLD.
Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients.
Cancers (Basel). 2020 Nov 7, 2020;12(11):3297. doi: 10.3390/cancers12113297. PMID: 33171819. Laboratory investigation. ˍ

Arpa D, Parisi E, Ghigi G, Savini A, Colangione SP, Tontini L, Pieri M, Foca F, Polico R, Tesei A, Sarnelli A, Romeo A.
Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy.
Sci Rep. 2020 Nov 9, 2020;10(1):19321. doi: 10.1038/s41598-020-75671-9. PMID: 33168845. Observational study. ˍ

Klein P, Tyrlikova I, Zuccoli G, Tyrlik A, Maroon JC.
Treatment of glioblastoma multiforme with "classic" 4:1 ketogenic diet total meal replacement.
Cancer Metab. 2020 Nov 9, 2020;8(1):24
. doi: 10.1186/s40170-020-00230-9. PMID: 33292598. Interventional study. ˍ

Niu X, Wang C, Zhou X, Yang Y, Liu Y, Zhang Y, Mao Q.
Pineal Region Glioblastomas: Clinical Characteristics, Treatment and Survival Outcome.
World Neurosurg. 2020 Nov 10, 2021;146:e799-e810. doi: 10.1016/j.wneu.2020.11.016. PMID: 33186787. Observational study. ˍ

Berzero G, Di Stefano AL, Ronchi S, Bielle F, Villa C, Guillerm E, Capelle L, Mathon B, Laurenge A, Giry M, Schmitt Y, Marie Y, Idbaih A, Hoang-Xuan K, Delattre JY, Mokhtari K, Sanson M.
IDH-wildtype lower grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification.
Neuro Oncol. 2020 Nov 11, 2021;23(6):955-966. doi: 10.1093/neuonc/noaa258. PMID: 33173941. Observational study. ˍ


Gramatzki D, Felsberg J, Roth P, Kaulich K, von Deimling A, Rushing EJ, Reifenberger G, Weller M.
The molecular evolution of glioblastoma treated by gross total resection alone.
Neuro Oncol. 2020 Nov 11, 2021;23(6):955-966. doi: 10.1093/neuonc/noaa261. PMID: 33173940. Observational study. ˍ

Hoffmann IL, Cardinalli IA, Yunes JA, Seidinger AL, Pereira RM.
Clinical, demographic, anatomopathological, and molecular findings in patients with medulloblastoma treated in a single health facility.
Rev Paul Pediatr. 2020 Nov 11, 2020;39:e2019298. doi: 10.1590/1984-0462/2021/39/2019298. PMID: 33206839. Observational study. ˍ

Sahebjam S, Forsyth PA, Tran ND, Arrington JA, Macaulay R, Etame AB, Walko CM, Boyle T, Peguero EN, Jaglal M, Mokhtari S, Enderling H, Raghunand N, Gatewood T, Long W, Dzierzeski JL, Evernden B, Robinson T, Wicklund MC, Kim S, Thompson ZJ, Chen DT, Chinnaiyan P, Yu HM.
Hypofractionated Stereotactic Re-Irradiation with Pembrolizumab and Bevacizumab in Patients with Recurrent High Grade Gliomas: Results from a Phase 1 Study.
Neuro Oncol. 2020 Nov 11, 2021;23(4):677-686. doi: 10.1093/neuonc/noaa260. PMID: 33173935. Interventional study. ˍ

Cho JH, Lim YC, Han KD, Lee JY, Choi JH.
The incidence of malignant brain tumors is increased in patients with obstructive sleep apnea: A national health insurance survey.
PLoS One. 2020 Nov 12, 2020;15(11):e0241598. doi: 10.1371/journal.pone.0241598. PMID: 33180841. Observational study. ˍ

Gallia GL, Holdhoff M, Brem H, Joshi AD, Hann CL, Bai RY, Staedtke V, Blakeley JO, Sengupta S, Jarrell TC, Wollett J, Szajna K, Helie N, Mattox AK, Ye X, Rudek MA, Riggins GJ.
Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial.
Neurooncol Adv. 2020 Nov 12, 2021;3(1):vdaa154
. doi: 10.1093/noajnl/vdaa154. PMID: 33506200. Interventional study. ˍ

Karschnia P, Teske N, Dorostkar MM, Siller S, Weller J, Baehring JM, Dietrich J, von Baumgarten L, Herms J, Tonn JC, Thon N.
Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II.
Sci Rep. 2020 Nov 12, 2020;10(1):19758. doi: 10.1038/s41598-020-76312-x. PMID: 33184319. Observational study. ˍ


Lawlor K, Marques-Torrejon MA, Dharmalingham G, El-Azhar Y, Schneider MD, Pollard SM, Rodrìguez TA.
Glioblastoma stem cells induce quiescence in surrounding neural stem cells via Notch signaing.
Genes Dev. 2020 Nov 12, 2020;34(23-24):1599-1604. doi: 10.1101/gad.336917.120. PMID: 33184225. Laboratory investigation. ˍ

Peng H, Huo J, Li B, Cui Y, Zhang H, Zhang L, Ma L.
Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features.
J Magn Reson Imaging. 2020 Nov 12, 2021;53(5):1399-1407. doi: 10.1002/jmri.27434. PMID: 33179832. Observational study. ˍ

Yang Z, Song J, Zhu W.
How I do it? Anatomical multifocal high-grade glioma resection.
Acta Neurochir (Wien). 2020 Nov 12, 2021;163(4):953-957. doi: 10.1007/s00701-020-04637-7. PMID: 33180195. Case report. ˍ

Nagtegaal SHJ, David S, Philippens MEP, Snijders TJ, Leemans A, Verhoeff JJC.
Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy.
Clin Transl Radiat Oncol. 2020 Nov 15, 2021;26:35-41
. doi: 10.1016/j.ctro.2020.11.005. PMID: 33294645. Observational study. ˍ